Type of security: Stock
Sector: Capital Goods
The data is delayed by 15 minutes.
Description: Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devi
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||1%||Sales Growth - Q/Q||-7.34%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||2.59%||ROE||5.84%||ROI||3.02%|
|Current Ratio||4.12||Quick Ratio||2.28||Long Term Debt/Equity||1.55||Debt Ratio||0.18|
|Gross Margin||62.28%||Operating Margin||7.77%||Net Profit Margin||4.24%||Dividend Payout Ratio|
|Cash From Financing Activities||30.45 M||Cash From Investing Activities||-18.74 M||Cash From Operating Activities||49.74 M||Gross Profit||157.54 M|
|Net Profit||5 M||Operating Profit||13.95 M||Total Assets||1.64 B||Total Current Assets||608.25 M|
|Total Current Liabilities||155.75 M||Total Debt||654.14 M||Total Liabilities||926.17 M||Total Revenue||244.08 M|
|High 52 week||67.23||Low 52 week||46.55||Last close||46.57||Last change||-2.45%|
|RSI||15.2||Average true range||1.68||Beta||0.65||Volume||390.34 K|
|Simple moving average 20 days||-8.72%||Simple moving average 50 days||-15.96%||Simple moving average 200 days||-22.19%|
|Performance Week||-6.49%||Performance Month||-14.2%||Performance Quart||-26.04%||Performance Half||-30.16%|
|Performance Year||-6.8%||Performance Year-to-date||-2.7%||Volatility daily||1.66%||Volatility weekly||3.72%|
|Volatility monthly||7.62%||Volatility yearly||26.39%||Relative Volume||322.8%||Average Volume||562.8 K|
|New High||New Low|
2019-01-11 09:39:02 | Integra LifeSciences Unveils Titan RSS-S, Widens Portfolio
2019-01-10 07:25:00 | Recent Analysis Shows T-Mobile US, Thor Industries, Integra LifeSciences, Diplomat Pharmacy, Tile Shop Hldgs, and Compass Diversified Market Influences — Renewed Outlook, Key Drivers of Growth
2019-01-10 06:30:00 | Integra LifeSciences Launches Integra® Titan™ Reverse Shoulder System-S
2019-01-09 09:15:02 | Integra IART Rises 5% on Robust Preliminary Q4 Results
2019-01-09 09:07:46 | Should We Worry About Integra LifeSciences Holdings Corporation’s NASDAQ:IART P/E Ratio?
2019-01-09 07:00:00 | Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director
2019-01-08 07:00:00 | Integra LifeSciences Announces Preliminary Fourth Quarter 2018 Financial Results
2018-12-24 09:22:02 | Integra Rides on Global Prospects, Hurt by Escalating Costs
2018-12-22 03:49:29 | Do Hedge Funds Love Integra Lifesciences Holdings Corp IART?
2018-12-18 16:01:00 | Integra LifeSciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
2018-12-12 12:13:00 | How Does Medtronic’s Restorative Therapies & Diabetes Group Look?
2018-11-30 09:31:02 | Integra IART Down 2.2% Since Last Earnings Report: Can It Rebound?
2018-11-28 10:02:03 | Integra's IART Margin Pressure Hurts, Global Prospects High
2018-11-08 16:01:00 | Integra LifeSciences to participate in Healthcare Conferences in November 2018
2018-11-07 08:15:00 | Detailed Research: Economic Perspectives on Integra LifeSciences, American Assets Trust, Teekay Offshore Partners, Acacia Communications, Piedmont Office Realty Trust, and Macerich — What Drives Growth in Today's Competitive Landscape
2018-11-01 12:20:04 | Integra IART Q3 Earnings Meet Estimates, Revenue View Dips
2018-10-31 16:38:47 | Edited Transcript of IART earnings conference call or presentation 31-Oct-18 12:30pm GMT
2018-10-31 07:30:11 | Integra LifeSciences IART Matches Q3 Earnings Estimates
2018-10-31 06:14:31 | Integra: 3Q Earnings Snapshot
2018-10-31 06:00:00 | Integra LifeSciences Reports Third Quarter 2018 Financial Results
2018-10-30 09:40:01 | Medical Product Stock Q3 Earnings on Oct 31: BAX, MASI & More
2018-10-24 10:31:02 | Integra LifeSciences IART Q3 Earnings Preview: What to Watch Ahead of the Release
2018-10-04 08:00:00 | New Research Coverage Highlights Harley-Davidson, Ritchie Bros. Auctioneers, Devon Energy, Dunkin' Brands Group, Acco Brands, and Integra LifeSciences — Consolidated Revenues, Company Growth, and Expectations for 2018
2018-09-19 16:01:00 | Integra LifeSciences to participate in the Cantor Global Healthcare Conference
2018-09-11 10:29:02 | Integra Lifesciences Picked for Healogics iSupply Program
2018-09-10 16:01:00 | Integra LifeSciences Selected for Healogics iSupply? Program
2018-08-24 10:24:02 | Why Is Integra IART Down 2.7% Since Last Earnings Report?
2018-08-21 15:41:23 | Are Integra LifeSciences Holdings Corporation’s NASDAQ:IART Interest Costs Too High?
2018-08-15 16:01:00 | Integra LifeSciences to Present at Healthcare Conferences in September 2018
2018-08-14 11:45:03 | Integra LifeSciences Codman Arm Strong, Competition Rife
2018-07-26 09:51:01 | Integra IART Reports In-Line Q2 Earnings, Tapers View
2018-07-25 17:13:09 | Edited Transcript of IART earnings conference call or presentation 25-Jul-18 12:30pm GMT
2018-07-25 06:30:00 | Integra LifeSciences Holdings Corporation to Host Earnings Call
2018-07-25 06:08:15 | Integra: 2Q Earnings Snapshot